| Business Summary | | Cyberonics,
Inc.
designs,
develops,
manufactures
and
markets
the
Neuro
Cybernetic
Prosthesis
(NCP)
System,
an
implantable
medical
device
for
the
treatment
of
epilepsy
and
other
debilitating
neurological,
psychiatric
diseases
and
other
disorders.
Cyberonics
operates
its
business
through
three
business
units,
which
include
the
Epilepsy
Business
Unit,
the
Depression
Business
Unit
and
the
Other
Indications
Business
Unit.
All
three
of
these
units
are
involved
in
the
designing,
developing,
manufacturing
and
marketing
of
the
Company's
proprietary
NCP
System
using
Vagus
Nerve
Stimulation
(VNS)
for
the
treatment
of
epilepsy
and
other
debilitating
neurological,
psychiatric
diseases
and
other
disorders. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Cyberonics,
Inc.
designs,
develops
and
markets
medical
devices
which
provide
a
novel
therapy,
vagus
nerve
stimulation
for
epilepsy
and
other
debilitating
neurological
disorders.
For
the
comparable
10
months
ended
4/27/01,
net
sales
rose
15%
to
$43.4
million.
Net
loss
before
acct.
change
totaled
$24.7
million,
up
from
$3.5
million.
Revenues
reflect
higher
sales
in
the
U.S.
market.
Higher
loss
reflects
a
$6.5
million
non-recurring
investment
banking
fee. Recent Earnings Announcement For
the
3
months
ended
07/27/2001,
revenues
were
14,615;
after
tax
earnings
were
-6,637. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Robert Cummins, 46 Chairman,
Pres, CEO | $410K | $2.5M | Pamela Westbrook, 42 VP
of Fin. and Admin. and CFO | 196K | 372K | Richard Kuntz, 49 VP,
Operations | 121K | -- | Shawn Lunney, 37 VP
of Sales | 159K | -- | Leonard Milke, 52 VP,
Marketing | -- | -- | Dollar
amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|